Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study

Purpose: The study aims to retrospectively investigate the efficacy and safety of sorafenib combined with transarterial chemoembolization (TACE) (TACE+Sor) vs. TACE combined with sorafenib plus immune checkpoint inhibitors (TACE+Sor+ICIs) in treating intermediate and advanced TACE-refractory hepatoc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Mol Biosci
Autores principales: Zheng, Liyun, Fang, Shiji, Wu, Fazong, Chen, Weiqian, Chen, Minjiang, Weng, Qiaoyou, Wu, Xulu, Song, Jingjing, Zhao, Zhongwei, Ji, Jiansong
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7843459/
https://ncbi.nlm.nih.gov/pubmed/33521054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmolb.2020.609322
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares